BSc MA - KTRA Old CoFounder Officer
Insider
BSc MA is CoFounder Officer of KTRA Old
| Age | 73 |
| Phone | 858 350 4364 |
| Web | https://www.kintara.com |
KTRA Old Management Efficiency
The company has return on total asset (ROA) of (1.0376) % which means that it has lost $1.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.7077) %, meaning that it created substantial loss on money invested by shareholders. KTRA Old's management efficiency ratios could be used to measure how well KTRA Old manages its routine affairs as well as how well it operates its assets and liabilities.KTRA Old currently holds 2.44 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. KTRA Old has a current ratio of 3.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about KTRA Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| David MBA | Lisata Therapeutics | 61 | |
| Christine MBA | SAB Biotherapeutics | 69 | |
| CPA CPA | GeoVax Labs | 62 | |
| Edith MD | Bolt Biotherapeutics | 67 | |
| Jon Patton | Oncolytics Biotech | N/A | |
| FACC FAHA | Milestone Pharmaceuticals | 66 | |
| Philippe MBA | Milestone Pharmaceuticals | 63 | |
| CPA CPA | Cellectar Biosciences | 60 | |
| Kristin Ainsworth | Seres Therapeutics | N/A | |
| Katherine Taudvin | Scpharmaceuticals | N/A | |
| Daniela Santiesteban | Salarius Pharmaceuticals | N/A | |
| Edgar MD | Bolt Biotherapeutics | 78 | |
| Lorenz Muller | Milestone Pharmaceuticals | 61 | |
| David MBA | Seres Therapeutics | 63 | |
| Steven CPA | Theriva Biologics | 64 | |
| Grey Wilkinson | Oncolytics Biotech | N/A | |
| Jeffrey Welch | GeoVax Labs | N/A | |
| Kimberly Sheehan | Milestone Pharmaceuticals | N/A | |
| CA CA | Oncolytics Biotech | N/A | |
| Randall Schatzman | Bolt Biotherapeutics | 69 | |
| Shane Lea | Cellectar Biosciences | N/A | |
Management Performance
| Return On Equity | -3.71 | |||
| Return On Asset | -1.04 |
KTRA Old Leadership Team
Elected by the shareholders, the KTRA Old's board of directors comprises two types of representatives: KTRA Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KTRA. The board's role is to monitor KTRA Old's management team and ensure that shareholders' interests are well served. KTRA Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KTRA Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BSc CPA, CFO Sec | ||
| BBA CPA, CEO Pres | ||
| BSc MA, CoFounder Officer | ||
| Greg Johnson, Acting Operations | ||
| CPA BBA, CEO and Presidentident |
KTRA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is KTRA Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.71 | |||
| Return On Asset | -1.04 | |||
| Current Valuation | 17.98 M | |||
| Shares Outstanding | 55.66 M | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 1.47 % | |||
| Number Of Shares Shorted | 5.43 M | |||
| Price To Book | 7.81 X | |||
| EBITDA | (8.5 M) | |||
| Net Income | (8.32 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in KTRA Stock
If you are still planning to invest in KTRA Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KTRA Old's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |